Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.
Jin Woo ChoiJin Wook ChungDong Ho LeeHyo-Cheol KimSaebeom HurMyungsu LeeHwan Jun JaePublished in: European radiology (2017)
• Portal hypertension was significantly associated with poor outcome after TACE. • Grading portal hypertension non-invasively can help predict TACE outcome in HCC patients. • CRPH grading can aid in selecting optimal candidates for TACE.